Sexual dysfunction in patients taking conventional antipsychotic medication
about
Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications.Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.Hypersexuality and dementia: dealing with inappropriate sexual expression.Women are not the same as men: specific clinical issues for female patients with bipolar disorder.High rates of sexual and urinary dysfunction after surgically treated displaced pelvic ring injuriesGender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.Neuroleptic medication and sexuality: the forgotten aspect of education and care.Detrimental effect of post Status Epilepticus treatment with ROCK inhibitor Y-27632 in a pilocarpine model of temporal lobe epilepsy.Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial.Impact of psychotropic medication on sexuality: literature review.A review of the association between antipsychotic use and hyperprolactinaemia.Antipsychotics and hyperprolactinaemia: clinical recommendations.Sex differences in schizophrenia.Gender differences in antipsychotic prescribing.Antipsychotic-induced hyperprolactinaemia.Use of asenapine in clinical practice for the management of bipolar mania.Lithium and sexual dysfunction: an under-researched area.Translation and cross-cultural adaptation of the Sexual Function Questionnaire (SFQ) into Brazilian Portuguese.'Veiling sexualities': a grounded theory of mental health nurses responses to issues of sexuality.Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy.Back to basics: informing the public of co-morbid physical health problems in those with mental illness.Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics.Opportunity lost? Psychiatric medications and problems with sexual function: a role for nurses in mental health.Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine.Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.Talking about sex as part of our role: making and sustaining practice change.Change in sexual dysfunction with aripiprazole: a switching or add-on study.The effect of chronic antipsychotic treatment on sexual behaviour, hormones and organ size in the male rat.Genetic determinants of selective serotonin reuptake inhibitor related sexual dysfunction.Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment.Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics.Sexuality and old age.Iatrogenic sexual dysfunction and the protective withholding of information: in whose best interest?The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness.The subjective experiences of people who regularly receive depot neuroleptic medication in the community.Developing a service to monitor and improve physical health in people with serious mental illness.
P2860
Q34296077-D60A2DDA-1138-4F79-A623-CCF082AA91A8Q34966395-C4D8CD61-C6AF-4D98-9C89-33B2E1A79DDDQ35755912-1F4A1EF0-AF64-4FF0-8407-6EABE3860E04Q36028124-DFF0E1BB-1ECB-4DD8-B90E-CDC0BD3DB36DQ36068766-A768DB04-A655-47B7-9536-B7641EE5FB79Q36083789-025D2271-55EF-482C-81C1-5B7993D2F16DQ36168604-E355334B-FF90-46B0-A10E-300A62DCCA27Q36191164-4738ED53-37F0-45A3-B98B-98EE633361C0Q36191787-D8AD5622-DF6D-4363-8764-E5430C6C8534Q36192428-1F7AB6A1-CA2C-4364-BE88-03762BC5AE22Q36841435-9D9F8F16-5D8C-4E4B-BEDE-D49D505734BCQ37162798-329CC9DA-1FAD-492F-819C-F2DCB50AD390Q37162821-98D5C447-C7BB-420D-AD12-ED4E99E276CAQ37806751-5D86D825-18D5-4AA1-B4BF-DD25EAF5B40BQ37806755-9AB5D5BD-FD59-4283-84EF-CC010A7B02A4Q37895702-D345A5A3-64FF-4996-8E00-F11C21BB5A5BQ38093728-39F6BC5A-2639-40DE-8B03-12BC2D93A7F4Q38331438-6DCA3BF9-D13A-495A-8387-6F933247CBE9Q39430513-1B8CC042-6C35-4D58-8245-2FA31078D9B7Q39843738-D9DB47D4-9F52-42EB-A75F-57A826ADA2B1Q41629589-C27D68B3-F303-4973-A30F-4F097C9F1839Q44127395-B3654DCF-8BC4-4ADB-B8A6-6B415EADB3F0Q44212820-BB7D7FC8-8942-4A4B-B81A-845D165ACFD7Q45002987-870C00EA-16A0-413E-ABCE-91C45C360FABQ46235015-9CD81B08-14E0-406C-B293-7CDE339ECAACQ46549460-469F2C75-5844-4617-B2FB-8046B14F26F4Q46597827-9A515B67-B2CA-4E40-9D32-2B91505DBF3BQ46680532-F4AE7F52-37BA-429D-9A12-09F25ACC74D7Q46727015-10FB8EC5-FABE-4FA3-BD2C-2E847E36BB8BQ47316983-1D1C6C04-58BD-4F90-9E01-0D311AB513BBQ48155028-32E4875B-25CC-4EC2-B107-C084DB5C6712Q50778360-CA1B3D74-2B9C-466B-95C2-341FEA384511Q50797154-63373797-4531-4D92-9C13-DA49F442B728Q50916772-26D8A363-0F19-488C-861A-13D39526EE15Q50930331-736321D2-0578-4549-9DEF-37DFD7126AC1Q51887432-C54C07CE-3B2F-43D7-982E-5F1250D8428CQ51900147-AE77B2C6-9BE3-476F-B92B-9E5D8596F93FQ51925964-5F55C2AE-3EB7-47C4-90A8-C8A03C2523B9
P2860
Sexual dysfunction in patients taking conventional antipsychotic medication
description
im Juli 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2002
@uk
name
Sexual dysfunction in patients taking conventional antipsychotic medication
@en
Sexual dysfunction in patients taking conventional antipsychotic medication
@nl
type
label
Sexual dysfunction in patients taking conventional antipsychotic medication
@en
Sexual dysfunction in patients taking conventional antipsychotic medication
@nl
prefLabel
Sexual dysfunction in patients taking conventional antipsychotic medication
@en
Sexual dysfunction in patients taking conventional antipsychotic medication
@nl
P50
P356
P1476
Sexual dysfunction in patients taking conventional antipsychotic medication
@en
P356
10.1192/BJP.181.1.49
P407
P577
2002-07-01T00:00:00Z